Metastatic carcinoma of unknown primary with complete metabolic response following sorafenib-based chemotherapy.

Usón Junior, Pedro Luiz Serrano; Wagner, Jairo; Corpa, Marcus Vinicius de Nigro; Coelho, Iracema Moraes; Nagourney, Robert A; Yamaguchi, Nise Hitomi

Usón Junior, Pedro Luiz Serrano; Wagner, Jairo; Corpa, Marcus Vinicius de Nigro; Coelho, Iracema Moraes; Nagourney, Robert A; Yamaguchi, Nise Hitomi.

Afiliação

Usón Junior PLS; Department of Oncology, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Wagner J; Department of Nuclear Medicine, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Corpa MVN; Department of Pathology, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Coelho IM; Department of Oncology, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Nagourney RA; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of California, Irvine, Irvine, CA, USA.
Yamaguchi NH; Department of Oncology, Hospital Israelita Albert Einstein, São Paulo, Brazil.

SAGE Open Med Case Rep ; 7: 2050313X19838739, 2019.

Article em En | MEDLINE | ID: mdl-30915220

Palavras-chave

Carcinoma of unknown primary; ferroptosis; sorafenib

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: SAGE Open Med Case Rep Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Brasil País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google